Normark S, Nilsson C, Normark BH, Hornef MW. Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res. 2003;90:63–89.

Article  PubMed  Google Scholar 

Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des. 2010;16(38):4225–36.

Article  CAS  PubMed  Google Scholar 

Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284(5418):1328–33.

Article  CAS  PubMed  Google Scholar 

Cho JH, Jin SY. Current guidelines for Helicobacter pylori treatment in East Asia 2022: differences among China, Japan, and South Korea. World J Clin Cases. 2022;10(19):6349–59.

Article  PubMed Central  PubMed  Google Scholar 

Wang R, Bai D, Xiang W, Zhang YF, Ba KY, Chen XZ. Helicobacter pylori prevalence in the Southwest of China: a protocol for systematic review. Medicine. 2020;99(11):e19369.

Article  PubMed Central  PubMed  Google Scholar 

Kamada T, Haruma K, Ito M, Inoue K, Manabe N, Matsumoto H, Kusunoki H, Hata J, Yoshihara M, Sumii K, et al. Time trends in Helicobacter pylori infection and Atrophic Gastritis over 40 years in Japan. Helicobacter. 2015;20(3):192–8.

Article  PubMed Central  PubMed  Google Scholar 

Zhu HM, Li BY, Tang Z, She J, Liang XY, Dong LK, Zhang M. Epidemiological investigation of Helicobacter pylori infection in elderly people in Beijing. World J Clin Cases. 2020;8(11):2173–80.

Article  PubMed Central  PubMed  Google Scholar 

Graham DY, Malaty HM, Evans DG, Evans DJ Jr., Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991;100(6):1495–501.

Article  CAS  PubMed  Google Scholar 

Abiko S, Hirayama Y, Otaki J, Harada Y, Kawakami K, Toi T, Takamiya T, Kawai T. Changes in prevalence of Helicobacter pylori in Japan from 2008 to 2018: a repeated cross-sectional study. BMJ Open. 2022;12(9):e058774.

Article  PubMed Central  PubMed  Google Scholar 

van Veldhuyzen SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994;169(2):434–7.

Article  Google Scholar 

Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136(2):487–90.

Article  CAS  PubMed  Google Scholar 

Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and Meta-analysis. Gastroenterology. 2017;153(2):420–9.

Article  PubMed  Google Scholar 

de Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci. 2006;51(12):2292–301.

Article  PubMed  Google Scholar 

Varga MG, Butt J, Blot WJ, Le Marchand L, Haiman CA, Chen Y, Wassertheil-Smoller S, Tinker LF, Peek RM Jr., Potter JD, et al. Racial differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of adult cohorts in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(10):2084–92.

Article  PubMed Central  PubMed  Google Scholar 

Rammohan R, Magam SG, Joy M, Natt D, Patel A, Tadikonda A, Desai J, Bunting S, Yost RM, Akande O, et al. Unpacking the racial gap: Helicobacter pylori infection clearance among different racial groups. Cureus. 2023;15(8):e43080.

PubMed Central  PubMed  Google Scholar 

Epplein M, Signorello LB, Zheng W, Peek RM Jr., Michel A, Williams SM, Pawlita M, Correa P, Cai Q, Blot WJ. Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev. 2011;20(5):826–34.

Article  PubMed Central  PubMed  Google Scholar 

den Hollander WJ, Holster IL, van Gilst B, van Vuuren AJ, Jaddoe VW, Hofman A, Perez-Perez GI, Kuipers EJ, Moll HA, Blaser MJ. Intergenerational reduction in Helicobacter pylori prevalence is similar between different ethnic groups living in a western city. Gut. 2015;64(8):1200–8.

Article  Google Scholar 

Xia X, Zhang L, Wu H, Chen F, Liu X, Xu H, Cui Y, Zhu Q, Wang M, Hao H, et al. CagA(+) Helicobacter pylori, not CagA(-) Helicobacter pylori, infection impairs endothelial function through exosomes-mediated ROS formation. Front Cardiovasc Med. 2022;9:881372.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Xue Z, You Y, He L, Gong Y, Sun L, Han X, Fan R, Zhai K, Yang Y, Zhang M, et al. Diversity of 3’ variable region of cagA gene in Helicobacter pylori strains isolated from Chinese population. Gut Pathog. 2021;13(1):23.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Takahashi-Kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol. 2020;17(1):50–63.

Article  CAS  PubMed  Google Scholar 

Nakano M, Yahiro K, Yamasaki E, Kurazono H, Akada J, Yamaoka Y, Niidome T, Hatakeyama M, Suzuki H, Yamamoto T, et al. Helicobacter pylori VacA, acting through receptor protein tyrosine phosphatase α, is crucial for CagA phosphorylation in human duodenum carcinoma cell line AZ-521. Dis Model Mech. 2016;9(12):1473–81.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Li H, Zhou Y, Zheng Y, Guo H, Gao L, Chen P, Feng D, Wu L, Yang M, Qi Y, et al. The gastric mucosa from patients infected with CagA + or VacA + Helicobacter pylori has a lower level of dual Oxidase-2 expression than uninfected or infected with CagA-/VacA- H. pylori. Dig Dis Sci. 2016;61(8):2328–37.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in latin American and African populations. Clin Microbiol Infect. 2009;15(9):835–42.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007;133(3):926–36.

Article  CAS  PubMed  Google Scholar 

Ren S, Cai P, Liu Y, Wang T, Zhang Y, Li Q, Gu Y, Wei L, Yan C, Jin G. Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2022;37(3):464–70.

Article  PubMed  Google Scholar 

Zhang F, Pu K, Wu Z, Zhang Z, Liu X, Chen Z, Ye Y, Wang Y, Zheng Y, Zhang J, et al. Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north-western China. Trop Med Int Health: TM IH. 2021;26(3):290–300.

Article  CAS  PubMed  Google Scholar 

Yang L, Kartsonaki C, Yao P, de Martel C, Plummer M, Chapman D, Guo Y, Clark S, Walters RG, Chen Y, et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study. Lancet Public Health. 2021;6(12):e888–96.

Article  PubMed Central  PubMed  Google Scholar 

Li R, Jiang XX, Zhang LF, Liu XM, Hu TZ, Xia XJ, Li M, Xu CX. Group 2 innate lymphoid cells are involved in Skewed Type 2 immunity of gastric diseases Induced by Helicobacter pylori Infection. Mediators Inflamm. 2017;2017:4927964.

Article  PubMed Central  PubMed  Google Scholar 

Liu W, Tian J, Hui W, Kong W, Feng Y, Si J, Gao F. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis. Sci Rep. 2021;11(1):4143.

Article  CAS  PubMed Central  PubMed  Google Scholar 

Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, Khan MN, Lan L, Jia CH, Zhang YR, et al. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cance